It has outperformed by 5.34% the S&P500. Raymond James Financial Services Advisors Inc. now owns 38,978 shares of the real estate investment trust’s stock worth $613,000 after buying an additional 3,515 shares during the period. Pivotal Research initiated the stock with “Sell” rating in Thursday, March 2 report. It is down 0.32% since June 16, 2016 and is uptrending. Cambridge Investment Research Inc owns 88,254 shares. It has underperformed by 16.70% the S&P500. Bank of New York Mellon Corp owned about 1.06% of New Residential Investment Corp. worth $55,346,000 as of its most recent filing with the SEC. $279,000 worth of New Residential Investment Corp (NYSE:NRZ) was bought by Nierenberg Michael on Friday, February 3. “Doesn’t Deserve Premium” on May 22, 2017.
Penn Mutual Life Insurance Company decreased Northstar Realty Finance Common Stk stake by 322,000 shares to 321,000 valued at $4.86M in 2016Q4. (NYSE:NRZ) now have an ABR of 1.00.which is marked on a basic 1 to 5 scale, where 1 stands for a Strong Buy and 5 represents Strong Sell.
Since February 3, 2017, it had 1 insider buy, and 0 selling transactions for $279,000 activity. Keefe, Bruyette & Woods set a $17.00 price target on New Residential Investment Corp. and gave the stock a “buy” rating in a research note on Tuesday, June 6th. Therefore 71% are positive.
Yorktown Management & Research Co Inc holds 6.18% of its portfolio in New Residential Investment Corp for 1.55 million shares. The firm earned “Mkt Outperform” rating on Wednesday, December 23 by JMP Securities. The firm has “Sell” rating by Zacks given on Wednesday, August 12.
Several equities analysts recently weighed in on NRZ shares. As per Wednesday, August 10, the company rating was maintained by Barclays Capital. The firm has “Neutral” rating given on Wednesday, October 26 by Nomura. On Friday, September 9 the stock rating was reinitiated by Piper Jaffray with “Overweight”. Vetr downgraded shares of New Residential Investment Corp. from a “buy” rating to a “hold” rating and set a $17.92 price target on the stock.in a report on Tuesday, April 11th. As per Monday, October 19, the company rating was upgraded by Piper Jaffray. The firm has “Outperform” rating given on Thursday, October 6 by Wedbush.
Investors sentiment decreased to 1.12 in 2016 Q4. Its down 0.16, from 0.98 in 2016Q3. 61 funds opened positions while 244 raised stakes. The company have shares float of 303.17 million. Jpmorgan Chase And holds 425,722 shares. 1,176 were accumulated by Robeco Institutional Asset Mgmt Bv. 501,406 are owned by California State Teachers Retirement System. Overweight rating was issued by 0 and Underweight rating was suggested by 0 Investors should trade with caution and watch out for further signals. Kingstown Limited Partnership reported 3.50 million shares. Commerzbank Aktiengesellschaft Fi owns 10,423 shares or 0% of their USA portfolio.
Pacer Advisors Inc. boosted its position in shares of New Residential Investment Corp. During the session shares stayed in the range from $16.68 to $16.39. NRZ price is down almost -7.07% from its 52-week high price of $17.86 a share but is up about 24.58% from its 52-week low price of $12.58 a share. Omers Administration reported 33,900 shares or 0.01% of all its holdings. First National Trust reported 18,058 shares stake. In that case, its shares would mark a 1.62% decline from the most recent price. Creative Planning owns 52,436 shares. More interesting news about Intercept Pharmaceuticals Inc (NASDAQ:ICPT) were released by: Streetinsider.com and their article: “Intercept Pharma (ICPT) Announces New Data Analysis From FLINT Trial of OCA in …” published on June 12, 2017 as well as Marketwatch.com’s news article titled: “Intercept Pharma’s new liver disease drug comes with hefty price tag: $70000 a …” with publication date: May 31, 2016. It turned negative, as 37 investors sold ICPT shares while 38 reduced holdings. The shares have moved 2.45% on the week. Tower Rech Limited (Trc) invested in 0.01% or 7,684 shares. Dreman Value Mngmt L L C has 29,302 shares for 0.26% of their portfolio. Art Ltd Liability Company accumulated 6,500 shares. Hong Kong-based Parametrica Management Ltd has invested 1.16% in Intercept Pharmaceuticals Inc (NASDAQ:ICPT). (NRZ) has a trading volume of 5.07 Million shares, with an average trading volume of 2870 shares – with shares dropping to a 52 week low of $12.58, and the company’s shares hitting a 52 week high of $ 17.86.